Compare MNDO & COSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MNDO | COSM |
|---|---|---|
| Founded | 1995 | 2009 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Other Pharmaceuticals |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.0M | 15.8M |
| IPO Year | 2000 | 2009 |
| Metric | MNDO | COSM |
|---|---|---|
| Price | $0.91 | $0.25 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 47.9K | ★ 705.9K |
| Earning Date | 05-08-2026 | 04-15-2026 |
| Dividend Yield | ★ 20.95% | N/A |
| EPS Growth | N/A | ★ 46.15 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $65,271,815.00 |
| Revenue This Year | N/A | $54.08 |
| Revenue Next Year | N/A | $32.66 |
| P/E Ratio | $8.57 | ★ N/A |
| Revenue Growth | N/A | ★ 19.93 |
| 52 Week Low | $0.85 | $0.25 |
| 52 Week High | $1.50 | $1.32 |
| Indicator | MNDO | COSM |
|---|---|---|
| Relative Strength Index (RSI) | 34.06 | 25.64 |
| Support Level | $0.89 | N/A |
| Resistance Level | $1.24 | $0.41 |
| Average True Range (ATR) | 0.04 | 0.02 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 30.62 | 6.18 |
MIND C.T.I. Ltd develops, manufactures, markets, and implements real-time and off-line convergent billing and customer care software solutions. It derives revenue from the sale of software products and services in two reportable segments, namely Billing and Related Services, which derives key revenue, and Messaging. The company has three product lines: Product Line A- billing and customer care solutions for service providers; Product Line B - call accounting and call management solutions for enterprises; and Product Line C - mobile messaging, communication, and payment solutions. Geographically, the company operates in the Americas, Europe, Asia Pacific and Africa, and Israel. It earns maximum revenue from Europe.
Cosmos Health Inc is a diversified, vertically integrated healthcare group, owner of proprietary pharmaceutical and nutraceutical brands, generics, manufacturer and distributor of healthcare products, engaged in research & development of medicines and repurposing drugs as well as operator of a telehealth platform. The company has developed its own proprietary branded nutraceutical products, named 'Sky Premium Life' and 'Mediterranation'. Its product portfolio includes generics and over-the-counter pharmaceutical products, medicines, as well as nutraceuticals and biocides. The company's Reportable segments are Wholesale, Pharma manufacturing, and Nutraceutical and pharmaceuticals, with the majority of revenue generated from the Wholesale segment.